Darolutamide (Nubeqa)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Darolutamide (Nubeqa), covering 2024-12-20 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies [Phase 3]